A novel matrix for the short-term storage of cells: utility in drug metabolism and drug transporter studies with rat, dog and human hepatocytes

References

• Aidasani D, Zaya MJ, Malpas PB, Locuson CW. (2008). In vitro drug-drug interaction screens for canine veterinary medicines: evaluation of cytochrome P450 reversible inhibition. Drug Metab Dispos 36:1512–1518.
   PubMed Web of Science ®Google Scholar
• Alexandre E, Viollon-Abadie C, David P, Gandillet A, Coassolo P, Heyd B, Mantion G, Wolf P, Bachellier P, Jaeck D, Richert L. (2002). Cryopreservation of adult human hepatocytes obtained from resected liver biopsies. Cryobiology 44:103–113.
   PubMed Web of Science ®Google Scholar
• Alvarez M, Rhodes SJ, Bidwell JP. (2003). Context-dependent transcription: all politics is local. Gene 313:43–57.
   PubMedGoogle Scholar
• Badolo L, Trancart MM, Gustavsson L, Chesné C. (2011). Effect of cryopreservation on the activity of OATP1B1/3 and OCT1 in isolated human hepatocytes. Chem Biol Interact 190:165–170.
   PubMed Web of Science ®Google Scholar
• Chiba Y, Yamashita Y, Ueno M, Fujisawa H, Hirayoshi K, Hohmura K, Tomimoto H, Akiguchi I, Satoh M, Shimada A, Hosokawa M. (2005). Cultured murine dermal fibroblast-like cells from senescence-accelerated mice as in vitro models for higher oxidative stress due to mitochondrial alterations. J Gerontol A Biol Sci Med Sci 60:1087–1098.
   Google Scholar
• Clayton DF, Darnell Jr JE. (1983). Changes in liver-specific compared to common gene transcription during primary culture of mouse hepatocytes. Mol Cell Biol 3:1552–1561.
   PubMed Web of Science ®Google Scholar
• Di Marco A, D’Antoni M, Attaccalite S, Carotenuto P, Laufer R. (2005). Determination of drug glucuronidation and UDP-glucuronosyltransferase selectivity using a 96-well radiometric assay. Drug Metab Dispos 33:812–819.
   PubMed Web of Science ®Google Scholar
• DiPersio CM, Jackson DA, Zaret KS. (1991). The extracellular matrix coordinately modulates liver transcription factors and hepatocyte morphology. Mol Cell Biol 11:4405–4414.
   PubMedGoogle Scholar
• Ghibellini G, Vasist LS, Leslie EM, Heizer WD, Kowalsky RJ, Calvo BF, Brouwer KL. (2007). In vitro-in vivo correlation of hepatobiliary drug clearance in humans. Clin Pharmacol Ther 81:406–413.
   PubMed Web of Science ®Google Scholar
• Griffin SJ, Houston RJ. (2004). Prediction of in vitro intrinsic clearance from hepatocytes: Comparison of suspension and monolayer cultures. Drug Metab Dispos 33:115–120.
   Google Scholar
• Grime K, Riley RJ. (2006). The impact of in vitro binding on in vitro-in vivo extrapolations, projections of metabolic clearance and clinical drug-drug interactions. Curr Drug Metab 7:251–264.
   PubMed Web of Science ®Google Scholar
• Grime K, Webborn PJ, Riley RJ. (2008). Functional consequences of active hepatic uptake on cytochrome P450 inhibition in rat and human hepatocytes. Drug Metab Dispos 36:1670–1678.
   PubMed Web of Science ®Google Scholar
• Grunstein M. (1997). Histone acetylation in chromatin structure and transcription. Nature 389:349–352.
   PubMed Web of Science ®Google Scholar
• Honkakoski P, Negishi M. (2000). Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem J 347:321–337.
   PubMed Web of Science ®Google Scholar
• Illouz S, Alexandre E, Pattenden C, Mark L, Bachellier P, Webb M, Berry D, Dennison A, Richert L. (2008). Differential effects of curcumin on cryopreserved versus fresh primary human hepatocytes. Phytother Res 22:1688–1691.
   Google Scholar
• Jefferson DM, Clayton DF, Darnell JE Jr, Reid LM. (1984). Posttranscriptional modulation of gene expression in cultured rat hepatocytes. Mol Cell Biol 4:1929–1934.
   PubMed Web of Science ®Google Scholar
• Kato M, Chiba K, Horikawa M, Sugiyama Y. (2005). The quantitative prediction of in vivo enzyme-induction caused by drug exposure from in vitro information on human hepatocytes. Drug Metab Pharmacokinet 20:236–243.
   PubMedGoogle Scholar
• Kenny JR, Grime K. (2006). Pharmacokinetic consequences of time-dependent inhibition using the isolated perfused rat liver model. Xenobiotica 36:351–365.
   PubMed Web of Science ®Google Scholar
• Kobayashi O, Sakaguchi M, Okitsu T, Totsugawa T, Maruyama M, Matsumura T, Watanabe T, Noguchi H, Kosaka Y, Fujiwara T, Tanaka N. (2002). Improvement in the differentiated hepatic phenotype of immortalized human hepatocytes by adenovirus mediated p21 gene transfer. ASAIO J 48:355–359.
   PubMed Web of Science ®Google Scholar
• Kusuhara H, Sugiyama Y. (2010). Pharmacokinetic modeling of the hepatobiliary transport mediated by cooperation of uptake and efflux transporters. Drug Metab Rev 42:539–550.
   PubMed Web of Science ®Google Scholar
• LeCluyse E, Madan A, Hamilton G, Carroll K, DeHaan R, Parkinson A. (2000). Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes. J Biochem Mol Toxicol 14:177–188.
   PubMed Web of Science ®Google Scholar
• Letschert K, Keppler D, König J. (2004). Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8). Pharmacogenetics 14:441–452.
   PubMedGoogle Scholar
• Li AP, Lu C, Brent JA, Pham C, Fackett A, Ruegg CE, Silber PM. (1999). Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. Chem Biol Interact 121:17–35.
   PubMed Web of Science ®Google Scholar
• Li AP. (2008). Human hepatocytes as an effective alternative experimental system for the evaluation of human drug properties: general concepts and assay procedures. ALTEX 25:33–42.
   PubMed Web of Science ®Google Scholar
• McGinnity DF, Soars MG, Urbanowicz RA, Riley RJ. (2004). Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance. Drug Metab Dispos 32:1247–1253.
   PubMed Web of Science ®Google Scholar
• McGinnity DF, Tucker J, Trigg S, Riley RJ. (2005). Prediction of CYP2C9-mediated drug-drug interactions: a comparison using data from recombinant enzymes and human hepatocytes. Drug Metab Dispos 33:1700–1707.
   PubMed Web of Science ®Google Scholar
• Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J. (2002). A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem 277:43058–43063.
   PubMed Web of Science ®Google Scholar
• Nakakariya M, Ono M, Amano N, Moriwaki T, Maeda K, Sugiyama Y. (2012). In vivo biliary clearance should be predicted by intrinsic biliary clearance in sandwich-cultured hepatocytes. Drug Metab Dispos 40:602–609.
   PubMed Web of Science ®Google Scholar
• Nozawa T, Nakajima M, Tamai I, Noda K, Nezu J, Sai Y, Tsuji A, Yokoi T. (2002). Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis. J Pharmacol Exp Ther 302:804–813.
   PubMed Web of Science ®Google Scholar
• O’Donnell CJ, Grime K, Courtney P, Slee D, Riley RJ. (2007). The development of a cocktail CYP2B6, CYP2C8, and CYP3A5 inhibition assay and a preliminary assessment of utility in a drug discovery setting. Drug Metab Dispos 35:381–385.
   PubMed Web of Science ®Google Scholar
• Parker AJ, Houston BJ. (2008). Rate-Limiting Steps in Hepatic Drug Clearance: Comparison of Hepatocellular Uptake and Metabolism with Microsomal Metabolism of Saquinavir, Nelfinavir, and Ritonavir. Drug Metab Dispos 36:1375–1384.
   PubMed Web of Science ®Google Scholar
• Rana B, Xie Y, Mischoulon D, Bucher NL, Farmer SR. (1995). The DNA binding activity of C/EBP transcription factor is regulated in the G1 phase of the hepatocyte cell cycle. J Biol Chem 270:18123–18132.
   PubMedGoogle Scholar
• Sahi J, Grepper S, Smith C. (2010). Hepatocytes as a tool in drug metabolism, transport and safety evaluations in drug discovery. Curr Drug Discov Technol 7:188–198.
   PubMedGoogle Scholar
• Saliem M, Holm F, Tengzelius RB, Jorns C, Nilsson LM, Ericzon BG, Ellis E, Hovatta O. (2012). Improved cryopreservation of human hepatocytes using a new xeno free cryoprotectant solution. World J Hepatol 4:176–183.
   Google Scholar
• Sasakawa Y, Naoe Y, Sogo N, Inoue T, Sasakawa T, Matsuo M, Manda T, Mutoh S. (2005). Marker genes to predict sensitivity to FK228, a histone deacetylase inhibitor. Biochem Pharmacol 69:603–616.
   PubMed Web of Science ®Google Scholar
• Schrem H, Klempnauer J, Borlak J. (2002). Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol Rev 54:129–158.
   PubMed Web of Science ®Google Scholar
• Seglen GB. (1976). Preparation of isolated rat liver cells. Methods Cell Biol 13:29–83.
   PubMedGoogle Scholar
• Shitara Y, Li AP, Kato Y, Lu C, Ito K, Itoh T, Sugiyama Y. (2003). Function of uptake transporters for taurocholate and estradiol 17beta-D-glucuronide in cryopreserved human hepatocytes. Drug Metab Pharmacokinet 18:33–41.
   PubMedGoogle Scholar
• Shitara Y, Hirano M, Sato H, Sugiyama Y. (2004). Gemfibrozil and its glucuronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin: analysis of the mechanism of the clinically relevant drug-drug interaction between cerivastatin and gemfibrozil. J Pharmacol Exp Ther 311:228–236.
   PubMed Web of Science ®Google Scholar
• Shou M, Norcross R, Sandig G, Lu P, Li Y, Lin Y, Mei Q, Rodrigues AD, Rushmore TH. (2003). Substrate specificity and kinetic properties of seven heterologously expressed dog cytochromes p450. Drug Metab Dispos 31:1161–1169.
   PubMed Web of Science ®Google Scholar
• Soars MG, Grime K, Sproston JL, Webborn PJ, Riley RJ. (2007). Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo. Drug Metab Dispos 35:859–865.
   PubMed Web of Science ®Google Scholar
• Soars MG, Fettes M, O’Sullivan AC, Riley RJ, Ethell BT, Burchell B. (2003). Cloning and characterisation of the first drug-metabolising canine UDP-glucuronosyltransferase of the 2B subfamily. Biochem Pharmacol 65:1251–1259.
   Google Scholar
• Sohlenius-Sternbeck AK, Schmidt S. (2005). Impaired glutathione-conjugating capacity by cryopreserved human and rat hepatocytes. Xenobiotica 35:727–736.
   PubMed Web of Science ®Google Scholar
• Terry C, Hughes RD, Mitry RR, Lehec SC, Dhawan A. (2007). Cryopreservation-induced nonattachment of human hepatocytes: role of adhesion molecules. Cell Transplant 16:639–647.
   PubMed Web of Science ®Google Scholar
• Terry C, Dhawan A, Mitry RR, Lehec SC, Hughes RD. (2010). Optimization of the cryopreservation and thawing protocol for human hepatocytes for use in cell transplantation. Liver Transpl 16:229–237.
   PubMed Web of Science ®Google Scholar
• Tirona RG, Leake BF, Merino G, Kim RB. (2001). Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans. J Biol Chem 276:35669–35675.
   PubMed Web of Science ®Google Scholar
• Tirona RG, Kim RB. (2005). Nuclear receptors and drug disposition gene regulation. J Pharm Sci 94:1169–1186.
   PubMed Web of Science ®Google Scholar
• Tucker GT, Houston JB, Huang SM. (2001). Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential-toward a consensus. Clin Pharmacol Ther 70:103–114.
   PubMedGoogle Scholar
• Weaver R, Graham KS, Beattie IG, Riley RJ. (2003). Cytochrome P450 inhibition using recombinant proteins and mass spectrometry/multiple reaction monitoring technology in a cassette incubation. Drug Metab Dispos 31:955–966.
   PubMed Web of Science ®Google Scholar
• Zhao P, Kunze KL, Lee CA. (2005). Evaluation of time-dependent inactivation of CYP3A in cryopreserved human hepatocytes. Drug Metab Dispos 33:853–861.
   PubMed Web of Science ®Google Scholar